Market by Drug Type, Technology, Service, End-user, and Region | Forecast 2019-2028
The global drug discovery market was projected to grow at a CAGR of 6.50% during the forecasting years 2019-2028. It was valued at $43.073 billion in 2019, is expected to reach $75.893 billion by 2028. Drug discovery is the process of identification, synthesis, classification, screening, and assaying of novel chemical candidates that could be developed into latent drugs.
Report scope can be customized per your requirements. Request For Customization
Along with the drug discovery services providers, the market for drug discovery devices and technologies is also witnessing a rise. Drug discovery technologies are used for the synthesis and extraction of the target compounds. Some of these technologies include qPCR, microarrays, high throughput screening, and others. Furthermore, the preference for small molecules, along with the growing technological advancements and the disease complications, lead the key players to surge their R&D expenditure, which is a key driver for the drug discovery market.
The
study aims to get an overview of the drug discovery market in terms of various
factors. The market definition and the key insights regarding the drug
discovery industry have been discussed within the report. Also, Porter's five
forces model, COVID-19 and its impact on the drug discovery market, regulatory outlook,
market attractiveness index, and PESTLE outlook have been studied in detail.
Market
drivers like the growing old age population, technological advancements, rise
in healthcare expenditure, and rise in lifestyle-oriented diseases are driving
the drug discovery market growth. However, the industry is facing restraints
like the delay in the launch of the products and the restricted development rate
due to generic drugs that are obstructing the industry growth.
Key
opportunities like substantial investment by healthcare organizations in
improving big data analytical abilities and the growing demand for specialty
medications can be leveraged by the industry to reach the projected growth.
However, challenges such as poor reimbursements procedures in developing nations
and strict government guidelines are being faced by this market.
Geographies covered in the drug discovery market by region are:
• North America: Canada and United
States
• Europe: United Kingdom, Germany,
Italy, Spain, France, Russia, and Rest of Europe
• Asia-Pacific: India, China, South
Korea, ASEAN countries, Japan, Australia & New Zealand, and Rest of
Asia-Pacific
• Latin America: Brazil, Mexico, and
Rest of Latin America
• Middle East and Africa: Turkey, South
Africa, United Arab Emirates, Saudi Arabia, and Rest of Middle East &
Africa
The drug discovery market has
been segmented as follows:
• By Technology
O Nanotechnology
O Combinatorial chemistry
O Pharmacogenetics and pharmacogenomics
O High throughput screening
O Metabolomics
O Bioinformatics
O Spectroscopy
O Biochips
O Other technologies
• By Drug Type
O Biologic drug
O Small molecule drug
• By Service
O Drug metabolism and pharmacokinetics
(DMPK) services
O Chemical services
O Biological services
O Other pharmaceutical services
• By End-user
O Contract research organizations (CROS)
O Research institutes
O Pharmaceutical companies
O Other end-users
The
key players engaged in the drug discovery market
are Sanofi, Novartis, GlaxoSmithKline LLC, Bayer AG, Pfizer Inc, Johnson & Johnson, Eli Lily and anofi, Novartis, GlaxoSmithKline LLC, Bayer AG, Pfizer Inc, Johnson & Johnson, Eli Lily and Company, Abbott Laboratories Inc, AstraZeneca Plc,
Antares Pharma Inc, Merck & Co Inc, 3M Company, F Hoffmann-La Roche Ltd,
Agilent Technologies Inc, Boehringer Ingelheim, and Becton Dickinson &
Company (BD).
The
strategic analysis for each of these companies has been covered in detail. The drug
discovery market by company profiles that helps to dive into the info about the
key players in this industry and the hold they have on the market.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. GLOBAL
DRUG DISCOVERY MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. MARKET
DEFINITION
2.2. PORTER'S
FIVE FORCES MODEL
2.2.1. THREATS
OF NEW ENTRANTS
2.2.2. THREAT
OF SUBSTITUTE PRODUCTS
2.2.3. BARGAINING
POWER OF BUYERS
2.2.4. BARGAINING
POWER OF SUPPLIERS
2.2.5. COMPETITIVE
RIVALRY
2.3. COVID-19
AND ITS IMPACT ON DRUG DISCOVERY MARKET
2.4. PESTLE
OUTLOOK
2.5. REGULATORY
FRAMEWORK
2.6. VALUE
CHAIN OUTLOOK
2.7. MARKET
ATTRACTIVENESS INDEX
2.8. KEY
INSIGHT
2.9. MARKET
DRIVERS
2.9.1. GROWING
AGED POPULATION
2.9.2. TECHNOLOGICAL
ADVANCEMENTS
2.9.3. RISE
IN HEALTHCARE EXPENDITURE
2.9.4. SURGE
IN LIFESTYLE-ORIENTED DISEASES
2.10. MARKET RESTRAINTS
2.10.1. DELAY IN PRODUCT LAUNCHES
2.10.2. RESTRICTED GROWTH RATE DUE TO
GENERIC DRUGS
2.11. MARKET OPPORTUNITIES
2.11.1. SIGNIFICANT INVESTMENT BY
HEALTHCARE INDUSTRIES IN IMPROVING BIG DATA ANALYTICAL CAPABILITIES
2.11.2. RISING DEMAND FOR SPECIALTY
MEDICINES
2.12. MARKET CHALLENGES
2.12.1. POOR REIMBURSEMENTS POLICIES
IN EMERGING NATIONS
2.12.2. STRINGENT GOVERNMENT
REGULATIONS
3. DRUG
DISCOVERY MARKET OUTLOOK - BY DRUG TYPE
3.1. SMALL
MOLECULE DRUG
3.2. BIOLOGIC
DRUG
4. DRUG
DISCOVERY MARKET OUTLOOK - BY TECHNOLOGY
4.1. HIGH
THROUGHPUT SCREENING
4.2. BIOCHIPS
4.3. BIOINFORMATICS
4.4. PHARMACOGENOMICS
AND PHARMACOGENETICS
4.5. COMBINATORIAL
CHEMISTRY
4.6. NANOTECHNOLOGY
4.7. SPECTROSCOPY
4.8. METABOLOMICS
4.9. OTHER
TECHNOLOGIES
5. DRUG
DISCOVERY MARKET OUTLOOK - BY SERVICE
5.1. DRUG
METABOLISM AND PHARMACOKINETICS (DMPK) SERVICES
5.2. CHEMICAL
SERVICES
5.3. BIOLOGICAL
SERVICES
5.4. OTHER
PHARMACEUTICAL SERVICES
6. DRUG
DISCOVERY MARKET OUTLOOK - BY END-USER
6.1. RESEARCH
INSTITUTES
6.2. PHARMACEUTICAL
COMPANIES
6.3. CONTRACT
RESEARCH ORGANIZATIONS (CROS)
6.4. OTHER
END-USERS
7. DRUG
DISCOVERY MARKET – REGIONAL OUTLOOK
7.1. NORTH
AMERICA
7.1.1. MARKET
BY TECHNOLOGY
7.1.2. MARKET
BY DRUG TYPE
7.1.3. MARKET
BY SERVICE
7.1.4. MARKET
BY END-USER
7.1.5. COUNTRY
ANALYSIS
7.1.5.1. UNITED
STATES
7.1.5.2. CANADA
7.2. EUROPE
7.2.1. MARKET
BY TECHNOLOGY
7.2.2. MARKET
BY DRUG TYPE
7.2.3. MARKET
BY SERVICE
7.2.4. MARKET
BY END-USER
7.2.5. COUNTRY
ANALYSIS
7.2.5.1. THE
UNITED KINGDOM
7.2.5.2. FRANCE
7.2.5.3. GERMANY
7.2.5.4. SPAIN
7.2.5.5. ITALY
7.2.5.6. RUSSIA
7.2.5.7. REST
OF EUROPE
7.3. ASIA-PACIFIC
7.3.1. MARKET
BY TECHNOLOGY
7.3.2. MARKET
BY DRUG TYPE
7.3.3. MARKET
BY SERVICE
7.3.4. MARKET
BY END-USER
7.3.5. COUNTRY
ANALYSIS
7.3.5.1. CHINA
7.3.5.2. INDIA
7.3.5.3. JAPAN
7.3.5.4. SOUTH
KOREA
7.3.5.5. AUSTRALIA
& NEW ZEALAND
7.3.5.6. ASEAN
COUNTRIES
7.3.5.7. REST
OF ASIA-PACIFIC
7.4. LATIN
AMERICA
7.4.1. MARKET
BY TECHNOLOGY
7.4.2. MARKET
BY DRUG TYPE
7.4.3. MARKET
BY SERVICE
7.4.4. MARKET
BY END-USER
7.4.5. COUNTRY
ANALYSIS
7.4.5.1. BRAZIL
7.4.5.2. MEXICO
7.4.5.3. REST
OF LATIN AMERICA
7.5. MIDDLE
EAST AND AFRICA
7.5.1. MARKET
BY TECHNOLOGY
7.5.2. MARKET
BY DRUG TYPE
7.5.3. MARKET
BY SERVICE
7.5.4. MARKET
BY END-USER
7.5.5. COUNTRY
ANALYSIS
7.5.5.1. SAUDI
ARABIA
7.5.5.2. TURKEY
7.5.5.3. UNITED
ARAB EMIRATES
7.5.5.4. SOUTH
AFRICA
7.5.5.5. REST
OF MIDDLE EAST & AFRICA
8. COMPANY
PROFILES
8.1. 3M
COMPANY
8.2. ABBOTT
LABORATORIES INC
8.3. AGILENT
TECHNOLOGIES INC
8.4. ANTARES
PHARMA INC
8.5. ASTRAZENECA
PLC
8.6. BAYER
AG
8.7. BECTON
DICKINSON & COMPANY (BD)
8.8. BOEHRINGER
INGELHEIM
8.9. ELI
LILY AND COMPANY
8.10. F HOFFMANN-LA ROCHE LTD
8.11. GLAXOSMITHKLINE LLC
8.12. JOHNSON & JOHNSON
8.13. MERCK & CO INC
8.14. NOVARTIS
8.15. PFIZER INC
8.16. SANOFI
9. RESEARCH
METHODOLOGY & SCOPE
9.1. RESEARCH
SCOPE & DELIVERABLES
9.1.1. OBJECTIVES
OF STUDY
9.1.2. SCOPE
OF STUDY
9.2. SOURCES
OF DATA
9.2.1. PRIMARY
DATA SOURCES
9.2.2. SECONDARY
DATA SOURCES
9.3. RESEARCH
METHODOLOGY
9.3.1. EVALUATION
OF PROPOSED MARKET
9.3.2. IDENTIFICATION
OF DATA SOURCES
9.3.3. ASSESSMENT
OF MARKET DETERMINANTS
9.3.4. DATA
COLLECTION
9.3.5. DATA
VALIDATION & ANALYSIS
TABLE
1 GLOBAL DRUG DISCOVERY MARKET, BY
REGION, 2019-2028 ($ MILLION)
TABLE
2 GLOBAL DRUG DISCOVERY MARKET, BY
DRUG TYPE, 2019-2028 ($ MILLION)
TABLE
3 GLOBAL DRUG DISCOVERY MARKET, BY TECHNOLOGY,
2019-2028 ($ MILLION)
TABLE
4 GLOBAL DRUG DISCOVERY MARKET, BY
SERVICE, 2019-2028 ($ MILLION)
TABLE
5 GLOBAL DRUG DISCOVERY MARKET, BY
END-USER, 2019-2028 ($ MILLION)
TABLE
6 GLOBAL DRUG DISCOVERY MARKET, BY
REGION, 2019-2028 ($ MILLION)
TABLE 7 NORTH AMERICA DRUG DISCOVERY MARKET, BY
TECHNOLOGY, 2019-2028 ($ MILLION)
TABLE
8 NORTH AMERICA DRUG DISCOVERY
MARKET, BY DRUG TYPE, 2019-2028 ($ MILLION)
TABLE
9 NORTH AMERICA DRUG DISCOVERY
MARKET, BY SERVICE, 2019-2028 ($ MILLION)
TABLE
10 NORTH AMERICA DRUG DISCOVERY
MARKET, BY END-USER, 2019-2028 ($ MILLION)
TABLE
11 NORTH AMERICA DRUG DISCOVERY
MARKET, BY COUNTRY, 2019-2028 ($ MILLION)
TABLE
12 EUROPE DRUG DISCOVERY MARKET, BY
TECHNOLOGY, 2019-2028 ($ MILLION)
TABLE
13 EUROPE DRUG DISCOVERY MARKET, BY
DRUG TYPE, 2019-2028 ($ MILLION)
TABLE
14 EUROPE DRUG DISCOVERY MARKET, BY
SERVICE, 2019-2028 ($ MILLION)
TABLE
15 EUROPE DRUG DISCOVERY MARKET, BY
END-USER, 2019-2028 ($ MILLION)
TABLE
16 EUROPE DRUG DISCOVERY MARKET, BY
COUNTRY, 2019-2028 ($ MILLION)
TABLE
17 ASIA-PACIFIC DRUG DISCOVERY
MARKET, BY TECHNOLOGY, 2019-2028 ($ MILLION)
TABLE
18 ASIA-PACIFIC DRUG DISCOVERY
MARKET, BY DRUG TYPE, 2019-2028 ($ MILLION)
TABLE
19 ASIA-PACIFIC DRUG DISCOVERY
MARKET, BY SERVICE, 2019-2028 ($ MILLION)
TABLE
20 ASIA-PACIFIC DRUG DISCOVERY
MARKET, BY END-USER, 2019-2028 ($ MILLION)
TABLE
21 ASIA-PACIFIC DRUG DISCOVERY
MARKET, BY COUNTRY, 2019-2028 ($ MILLION)
TABLE
22 LATIN AMERICA DRUG DISCOVERY
MARKET, BY TECHNOLOGY, 2019-2028 ($ MILLION)
TABLE
23 LATIN AMERICA DRUG DISCOVERY
MARKET, BY DRUG TYPE, 2019-2028 ($ MILLION)
TABLE
24 LATIN AMERICA DRUG DISCOVERY
MARKET, BY SERVICE, 2019-2028 ($ MILLION)
TABLE
25 LATIN AMERICA DRUG DISCOVERY
MARKET, BY END-USER, 2019-2028 ($ MILLION)
TABLE
26 LATIN AMERICA DRUG DISCOVERY MARKET,
BY COUNTRY, 2019-2028 ($ MILLION)
TABLE
27 MIDDLE EAST AND AFRICA DRUG
DISCOVERY MARKET, BY TECHNOLOGY, 2019-2028 ($ MILLION)
TABLE
28 MIDDLE EAST AND AFRICA DRUG
DISCOVERY MARKET, BY DRUG TYPE, 2019-2028 ($ MILLION)
TABLE
29 MIDDLE EAST AND AFRICA DRUG
DISCOVERY MARKET, BY SERVICE, 2019-2028 ($ MILLION)
TABLE
30 MIDDLE EAST AND AFRICA DRUG
DISCOVERY MARKET, BY END-USER, 2019-2028 ($ MILLION)
TABLE
31 MIDDLE EAST AND AFRICA DRUG
DISCOVERY MARKET, BY COUNTRY, 2019-2028 ($ MILLION)
FIGURE
1 GLOBAL DRUG DISCOVERY MARKET, BY
REGION, 2019-2028 ($ MILLION)
FIGURE
2 GLOBAL DRUG DISCOVERY MARKET, BY
SMALL MOLECULE DRUG, 2019-2028 ($ MILLION)
FIGURE
3 GLOBAL DRUG DISCOVERY MARKET, BY
BIOLOGIC DRUG, 2019-2028 ($ MILLION)
FIGURE
4 GLOBAL DRUG DISCOVERY MARKET, BY
HIGH THROUGHPUT SCREENING, 2019-2028 ($ MILLION)
FIGURE
5 GLOBAL DRUG DISCOVERY MARKET, BY
BIOCHIPS, 2019-2028 ($ MILLION)
FIGURE
6 GLOBAL DRUG DISCOVERY MARKET, BY
BIOINFORMATICS, 2019-2028 ($ MILLION)
FIGURE
7 GLOBAL DRUG DISCOVERY MARKET, BY
PHARMACOGENOMICS AND PHARMACOGENETICS, 2019-2028 ($ MILLION)
FIGURE
8 GLOBAL DRUG DISCOVERY MARKET, BY
COMBINATORIAL CHEMISTRY, 2019-2028 ($ MILLION)
FIGURE
9 GLOBAL DRUG DISCOVERY MARKET, BY
NANOTECHNOLOGY, 2019-2028 ($ MILLION)
FIGURE
10 GLOBAL DRUG DISCOVERY MARKET, BY
SPECTROSCOPY, 2019-2028 ($ MILLION)
FIGURE
11 GLOBAL DRUG DISCOVERY MARKET, BY
METABOLOMICS, 2019-2028 ($ MILLION)
FIGURE
12 GLOBAL DRUG DISCOVERY MARKET, BY
OTHER TECHNOLOGIES, 2019-2028 ($ MILLION)
FIGURE
13 GLOBAL DRUG DISCOVERY MARKET, BY DRUG
METABOLISM AND PHARMACOKINETICS (DMPK) SERVICES, 2019-2028 ($ MILLION)
FIGURE
14 GLOBAL DRUG DISCOVERY MARKET, BY
CHEMICAL SERVICES, 2019-2028 ($ MILLION)
FIGURE
15 GLOBAL DRUG DISCOVERY MARKET, BY
BIOLOGICAL SERVICES, 2019-2028 ($ MILLION)
FIGURE
16 GLOBAL DRUG DISCOVERY MARKET, BY
OTHER PHARMACEUTICAL SERVICES, 2019-2028 ($ MILLION)
FIGURE
17 GLOBAL DRUG DISCOVERY MARKET, BY
RESEARCH INSTITUTES, 2019-2028 ($ MILLION)
FIGURE
18 GLOBAL DRUG DISCOVERY MARKET, BY
PHARMACEUTICAL COMPANIES, 2019-2028 ($ MILLION)
FIGURE
19 GLOBAL DRUG DISCOVERY MARKET, BY
CONTRACT RESEARCH ORGANIZATIONS (CROS), 2019-2028 ($ MILLION)
FIGURE
20 GLOBAL DRUG DISCOVERY MARKET, BY
OTHER END-USERS, 2019-2028 ($ MILLION)
FIGURE
21 UNITED STATES DRUG DISCOVERY MARKET 2019-2028
($ MILLION)
FIGURE
22 CANADA DRUG DISCOVERY MARKET
2019-2028 ($ MILLION)
FIGURE
23 THE UNITED KINGDOM DRUG DISCOVERY
MARKET 2019-2028 ($ MILLION)
FIGURE
24 FRANCE DRUG DISCOVERY MARKET
2019-2028 ($ MILLION)
FIGURE
25 GERMANY DRUG DISCOVERY MARKET 2019-2028
($ MILLION)
FIGURE
26 SPAIN DRUG DISCOVERY MARKET 2019-2028
($ MILLION)
FIGURE
27 ITALY DRUG DISCOVERY MARKET 2019-2028
($ MILLION)
FIGURE
28 RUSSIA DRUG DISCOVERY MARKET
2019-2028 ($ MILLION)
FIGURE
29 REST OF EUROPE DRUG DISCOVERY MARKET
2019-2028 ($ MILLION)
FIGURE
30 CHINA DRUG DISCOVERY MARKET 2019-2028
($ MILLION)
FIGURE
31 INDIA DRUG DISCOVERY MARKET 2019-2028
($ MILLION)
FIGURE
32 JAPAN DRUG DISCOVERY MARKET 2019-2028
($ MILLION)
FIGURE
33 SOUTH KOREA DRUG DISCOVERY MARKET
2019-2028 ($ MILLION)
FIGURE
34 AUSTRALIA & NEW ZEALAND DRUG
DISCOVERY MARKET 2019-2028 ($ MILLION)
FIGURE
35 ASEAN COUNTRIES DRUG DISCOVERY MARKET
2019-2028 ($ MILLION)
FIGURE
36 REST OF ASIA-PACIFIC DRUG DISCOVERY
MARKET 2019-2028 ($ MILLION)
FIGURE
37 BRAZIL DRUG DISCOVERY MARKET
2019-2028 ($ MILLION)
FIGURE
38 MEXICO DRUG DISCOVERY MARKET
2019-2028 ($ MILLION)
FIGURE
39 REST OF LATIN AMERICA DRUG DISCOVERY
MARKET 2019-2028 ($ MILLION)
FIGURE
40 SAUDI ARABIA DRUG DISCOVERY MARKET
2019-2028 ($ MILLION)
FIGURE
41 TURKEY DRUG DISCOVERY MARKET
2019-2028 ($ MILLION)
FIGURE
42 UNITED ARAB EMIRATES DRUG DISCOVERY
MARKET 2019-2028 ($ MILLION)
FIGURE
43 SOUTH AFRICA DRUG DISCOVERY MARKET
2019-2028 ($ MILLION)
FIGURE 44 REST OF MIDDLE EAST & AFRICA DRUG DISCOVERY MARKET 2019-2028 ($ MILLION)